DENTSPLY SIRONA earnings release, May 5, 2026

DENTSPLY SIRONA Inc. (XRAY) · Form 8-K, Item 2.02 · Filed · SEC filing

Dentsply Sirona Reports First Quarter 2026

Results

News Summary

• Reported net sales of $880 million

• Delivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05)

• Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27

• Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across Europe

• Continued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreement

• Installed first CEREC® system under the new Benco Dental distribution agreement, marking an important early milestone

• Began implementing new capital allocation strategy by reducing debt, managing liquidity, and improving working capital

• Reiterated 2026 outlook for net sales and adjusted EPS

Charlotte, N.C., May 5, 2026 -

DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026.

“We are executing our Return-to-Growth Action Plan as expected, and our first quarter results reflect our current stage of transformation,” said Dan Scavilla, President and Chief Executive Officer of Dentsply Sirona. “While near-term performance is impacted by external pressures and investment timing, we are making solid progress toward sustainable growth.

"During the quarter, we advanced our commercial restructuring and continued portfolio innovation, with early traction from distributor partners. We remain confident in our strategy, maintain our full-year outlook, and expect momentum to build throughout the year.”

Q1 2026 Summary Results (Reported)

Q1 2026 Summary Results (Non-GAAP)

NM - not meaningful

Percentages are based on actual values and may not reconcile due to rounding.

[1]

Weighted-average shares outstanding used to calculate diluted loss per share for the first quarter of 2026 excludes potential dilutive common shares.

New Regional Reporting

Beginning in the three months ended March 31, 2026, the Company's geographic regions for reporting net sales were revised to consist of countries in (i) North and South America ("Americas"), (ii) Europe, the Middle East, and Africa ("EMEA"), and (iii) Asia Pacific ("APAC"). The revised regions align with how the Company manages commercial activities and reports net sales internally. This change did not impact the Company's consolidated financial statements and prior period amounts have been recast to conform to the current period presentation.

Cash Flow and Liquidity

Operating cash flow in the first quarter of 2026 was $40 million, compared to $7 million in the first quarter of 2025, primarily due to favorable collections on accounts receivable. Free cash flow, a Non-GAAP measure, in the first quarter of 2026 was ($12) million compared to ($12) million in the first quarter of 2025. The Company had $190 million of cash and cash equivalents as of March 31, 2026.

2026 Outlook

The Company is maintaining its 2026 outlook for net sales in the range of $3.5 billion to $3.6 billion and adjusted EPS in the range of $1.40 to $1.50.

We are unable to present a quantitative reconciliation of our expected earnings per diluted share to expected adjusted earnings per diluted share as we are unable to predict with reasonable certainty and without unreasonable effort, items which may include, but are not limited to, restructuring charges, transformation-related costs, impairment charges, certain tax adjustments, and other significant items. The financial impact of these items is uncertain and is dependent on various factors, including timing, and could be material to our Consolidated Statements of Operations.

Conference Call/Webcast Information

Dentsply Sirona's management team will host an investor conference call and live webcast on May 5, 2026, at 4:30 p.m. ET. The live webcast and a presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

For those planning to participate on the call, please register at http://register-conf.media-server.com/register/BIc1c93f4a84c14e3ea70e14bf07b0e306. A webcast replay of the conference call will be available on the Investors section of the Company's website following the call.

About Dentsply Sirona

Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information:

Investors:

Wade Moody

Senior Manager, Investor Relations

Investorrelations@dentsplysirona.com

Press:

Marion Par-Weixlberger

Vice President, Public Relations, Corporate Communications & Brand

Publicrelations@dentsplysirona.com

Financial statements

Income Statement

Twelve Months Ended December 31, 2024

Twelve Months Ended December 31, 2024 – Gross ProfitTwelve Months Ended December 31, 2024 – Operating (Loss) IncomeTwelve Months Ended December 31, 2024 – (Benefit) Provision for Income TaxesTwelve Months Ended December 31, 2024 – Net (Loss) Income Attributable to Dentsply SironaTwelve Months Ended December 31, 2024 – Diluted (Loss) Earnings per Share
GAAP1,958-879-26-910-4.48
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets122216571590.78
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a)6136301060.53
Non-GAAP Adjustments:Goodwill and Intangible Asset Impairments1,0141448704.27
Non-GAAP Adjustments:Business Combination-Related Costs and Fair Value Adjustments24130.01
Non-GAAP Adjustments:Fair Value and Credit Risk Adjustments20.01
Non-GAAP Adjustments:Income Tax-Related Adjustments (b)-99990.49
Non-GAAP Adjustments:Adjusted Non-GAAP2,0884911073291.61
Non-GAAP Adjustments:GAAP Margin-23.2
Non-GAAP Adjustments:Adjusted Non-GAAP Margin12.9

Income Statement

Three Months Ended June 30, 2025 — Percentages are based on actual values and may not reconcile due to rounding.

Three Months Ended June 30, 2025 – Gross ProfitThree Months Ended June 30, 2025 – Operating (Loss) IncomeThree Months Ended June 30, 2025 – (Benefit) Provision for Income TaxesThree Months Ended June 30, 2025 – Net (Loss) Income Attributable to Dentsply SironaThree Months Ended June 30, 2025 – Diluted (Loss) Earnings per Share
GAAP490-128-109-45-0.22
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets325414400.2
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a)514
Non-GAAP Adjustments:Goodwill and Intangible Asset Impairments235212141.07
Non-GAAP Adjustments:Business Combination-Related Costs14130.01
Non-GAAP Adjustments:Fair Value and Credit Risk Adjustments-4
Non-GAAP Adjustments:Income Tax-Related Adjustments (b)107-107-0.54
Non-GAAP Adjustments:Adjusted Non-GAAP523170351050.52
Non-GAAP Adjustments:GAAP Margin52.4-13.7
Non-GAAP Adjustments:Adjusted Non-GAAP Margin55.918.2

Income Statement

Three Months Ended September 30, 2025 — Percentages are based on actual values and may not reconcile due to rounding.

Three Months Ended September 30, 2025 – Gross ProfitThree Months Ended September 30, 2025 – Operating (Loss) IncomeThree Months Ended September 30, 2025 – (Benefit) Provision for Income TaxesThree Months Ended September 30, 2025 – Net (Loss) Income Attributable to Dentsply SironaThree Months Ended September 30, 2025 – Diluted (Loss) Earnings per Share
GAAP441-218198-427-2.14
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets335615410.21
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a)117-3200.1
Non-GAAP Adjustments:Goodwill and Intangible Asset Impairments262-12631.31
Non-GAAP Adjustments:Business Combination-Related Costs2110.01
Non-GAAP Adjustments:Income Tax-Related Adjustments (b)-1861860.93
Non-GAAP Adjustments:Adjusted Non-GAAP47511924840.42
Non-GAAP Adjustments:GAAP Margin48.8-24
Non-GAAP Adjustments:Adjusted Non-GAAP Margin52.613.2

Income Statement

Three Months Ended December 31, 2025 — Percentages are based on actual values and may not reconcile due to rounding.

Three Months Ended December 31, 2025 – Gross ProfitThree Months Ended December 31, 2025 – Operating (Loss) IncomeThree Months Ended December 31, 2025 – (Benefit) Provision for Income TaxesThree Months Ended December 31, 2025 – Net (Loss) Income Attributable to Dentsply SironaThree Months Ended December 31, 2025 – Diluted (Loss) Earnings per Share
GAAP443-139-2-146-0.74
Reported percent net sales46.2-14.5
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets335615410.21
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a)215960.04
Non-GAAP Adjustments:Goodwill and Intangible Asset Impairments15391440.72
Non-GAAP Adjustments:Business Combination-Related Costs and Fair Value Adjustments111
Non-GAAP Adjustments:Income Tax-Related Adjustments (b)2-2-0.01
Non-GAAP Adjustments:Adjusted4798633440.22
Non-GAAP Adjustments:Adjusted percent of net sales49.88.9

Income Statement

Twelve Months Ended December 31, 2025 — Percentages are based on actual values and may not reconcile due to rounding.

Twelve Months Ended December 31, 2025 – Gross ProfitTwelve Months Ended December 31, 2025 – Operating (Loss) IncomeTwelve Months Ended December 31, 2025 – (Benefit) Provision for Income TaxesTwelve Months Ended December 31, 2025 – Net (Loss) Income Attributable to Dentsply SironaTwelve Months Ended December 31, 2025 – Diluted (Loss) Earnings per Share
GAAP1,840-422112-598-3
Reported percent net sales50-11.5
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets126211561550.78
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a) (b)36113440.22
Non-GAAP Adjustments:Goodwill and Intangible Asset Impairments650306203.1
Non-GAAP Adjustments:Business Combination-Related Costs and Fair Value Adjustments28260.03

Income Statement

Q1 2026 Summary Results (Reported) (in millions, except per share amount and percentages)

Q1 26Q1 25YoY
Net Sales8808790.1%
Gross Profit427466-8.3%
Gross Margin48.5%53.0%
Net (Loss) Income Attributable to Dentsply Sirona-1020NM
Diluted (Loss) Earnings Per Share1-0.050.1NM

Income Statement

Three Months Ended March 31, — (unaudited)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net sales880879
Cost of products sold453413
Gross profit427466
Selling, general, and administrative expenses351358
Research and development expenses4436
Restructuring and other costs679
Operating (loss) income-3563
Other income and expenses:Interest expense, net2419
Other income and expenses:Other (income) expense, net-17
Other income and expenses:(Loss) income before income taxes-4244
Other income and expenses:(Benefit) provision for income taxes-3225
Other income and expenses:Net (loss) income-1019
Other income and expenses:Less: Net loss attributable to noncontrolling interest-1
Other income and expenses:Net (loss) income attributable to Dentsply Sirona-1020
(Loss) earnings per common share attributable to Dentsply Sirona:Basic-0.050.1
(Loss) earnings per common share attributable to Dentsply Sirona:Diluted-0.050.1
Weighted average common shares outstanding:Basic199.9199.1
Weighted average common shares outstanding:Diluted199.9199.8

Income Statement

Three Months Ended March 31, 2026

Three Months Ended March 31, 2026 – Gross ProfitThree Months Ended March 31, 2026 – Operating (Loss) IncomeThree Months Ended March 31, 2026 – (Benefit) Provision for Income TaxesThree Months Ended March 31, 2026 – Net (loss) Income Attributable to Dentsply SironaThree Months Ended March 31, 2026 – Diluted (Loss) Earnings per Share
Reported427-35-32-10-0.05
Reported percent net sales48.5-4
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets194211310.15
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a) (b)17418500.25
Non-GAAP Adjustments:Income Tax-Related Adjustments (c)17-17-0.08
Non-GAAP Adjustments:Adjusted4478114540.27
Non-GAAP Adjustments:Adjusted percent net sales50.79.2

Income Statement

Three Months Ended March 31, 2025 — Percentages are based on actual values and may not reconcile due to rounding.

Three Months Ended March 31, 2025 – Gross ProfitThree Months Ended March 31, 2025 – Operating (loss) incomeThree Months Ended March 31, 2025 – (Benefit) Provision for Income TaxesThree Months Ended March 31, 2025 – Net Income Attributable to Dentsply SironaThree Months Ended March 31, 2025 – Diluted Earnings per Share
Reported4666325200.1
Reported percent net sales537.1
Non-GAAP Adjustments:Amortization of Purchased Intangible Assets284512330.16
Non-GAAP Adjustments:Restructuring-Related Charges and Other Costs (a)256190.1
Non-GAAP Adjustments:Business Combination-Related Costs111
Non-GAAP Adjustments:Income Tax-Related Adjustments (b)-15150.08
Non-GAAP Adjustments:Adjusted49513428880.44
Non-GAAP Adjustments:Adjusted percent net sales56.315.1

Income Statement

Three Months Ended March 31, — Reconciliations of reported net (loss) income attributable to Dentsply Sirona to adjusted EBITDA and margin are as follows:

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net (loss) income attributable to Dentsply Sirona-1020
Interest expense, net2419
(Benefit) provision for income taxes-3225
Depreciation(1)3833
Amortization of intangible assets4145
Restructuring-related charges and other costs6825
Business combination-related costs and fair value adjustments1
Adjusted EBITDA129168
Net sales880879
Adjusted EBITDA margin14.719

Balance Sheet

March 31, 2026 — (unaudited)

March 31, 2026December 31, 2025
Current Assets:Cash and cash equivalents190326
Current Assets:Accounts and notes receivable-trade, net622688
Current Assets:Inventories, net659642
Current Assets:Prepaid expenses and other current assets374367
Current Assets:Total Current Assets1,8452,023
Current Assets:Property, plant, and equipment, net858861
Current Assets:Operating lease right-of-use assets, net139139
Current Assets:Identifiable intangible assets, net924974
Current Assets:Goodwill1,1421,148
Current Assets:Other noncurrent assets321284
Current Assets:Total Assets5,2295,429
Current Liabilities:Accounts payable259300
Current Liabilities:Accrued liabilities688700
Current Liabilities:Income taxes payable3030
Current Liabilities:Notes payable and current portion of long-term debt230313
Current Liabilities:Total Current Liabilities1,2071,343
Current Liabilities:Long-term debt2,0062,015
Current Liabilities:Operating lease liabilities9593
Current Liabilities:Deferred income taxes8494
Current Liabilities:Other noncurrent liabilities518544
Current Liabilities:Total Liabilities3,9104,089
Current Liabilities:Total Equity1,3191,340
Current Liabilities:Total Liabilities and Equity5,2295,429

Cash Flow

Three Months Ended March 31, — A reconciliation of free cash flow for the three months ended March 31, 2026 and 2025 is as follows:

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net cash provided by operating activities407
Capital expenditures-52-19
Free cash flow-12-12
Full release

Forward-Looking Statements and Associated Risks... (truncated)-K, Part II, Item 1A, "Risk Factors" of the Company's Quarterly Reports on Form 10-Q for any subsequent fiscal quarters, and any updating information or other factors which may be described in the Company's other filings with the Securities and Exchange Commission (the "SEC"). No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Press Release or to reflect the occurrence of unanticipated events. Investors should understand it is not possible to predict or identify all such factors or risks. As such, you should not consider the risks identified in the Company's SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · DENTSPLY SIRONA earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.